1. Home
  2. ENSC vs DGLY Comparison

ENSC vs DGLY Comparison

Compare ENSC & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • DGLY
  • Stock Information
  • Founded
  • ENSC 2003
  • DGLY 2004
  • Country
  • ENSC United States
  • DGLY United States
  • Employees
  • ENSC N/A
  • DGLY N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ENSC Health Care
  • DGLY Technology
  • Exchange
  • ENSC Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • ENSC 4.9M
  • DGLY 4.1M
  • IPO Year
  • ENSC N/A
  • DGLY N/A
  • Fundamental
  • Price
  • ENSC $2.22
  • DGLY $2.23
  • Analyst Decision
  • ENSC
  • DGLY
  • Analyst Count
  • ENSC 0
  • DGLY 0
  • Target Price
  • ENSC N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • ENSC 230.3K
  • DGLY 467.9K
  • Earning Date
  • ENSC 08-13-2025
  • DGLY 08-15-2025
  • Dividend Yield
  • ENSC N/A
  • DGLY N/A
  • EPS Growth
  • ENSC N/A
  • DGLY N/A
  • EPS
  • ENSC N/A
  • DGLY N/A
  • Revenue
  • ENSC $6,224,081.00
  • DGLY $18,596,715.00
  • Revenue This Year
  • ENSC N/A
  • DGLY N/A
  • Revenue Next Year
  • ENSC $1,381.48
  • DGLY N/A
  • P/E Ratio
  • ENSC N/A
  • DGLY N/A
  • Revenue Growth
  • ENSC 256.35
  • DGLY N/A
  • 52 Week Low
  • ENSC $1.62
  • DGLY $1.93
  • 52 Week High
  • ENSC $14.67
  • DGLY $265.00
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 49.53
  • DGLY 24.67
  • Support Level
  • ENSC $2.02
  • DGLY $2.21
  • Resistance Level
  • ENSC $2.30
  • DGLY $2.59
  • Average True Range (ATR)
  • ENSC 0.14
  • DGLY 0.26
  • MACD
  • ENSC 0.02
  • DGLY 1.82
  • Stochastic Oscillator
  • ENSC 43.40
  • DGLY 5.04

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: